Biotechnology and Software Patent Law
Show Less

Biotechnology and Software Patent Law

A Comparative Review of New Developments

Edited by Emanuela Arezzo and Gustavo Ghidini

The new millennium has carried several challenges for patent law. This up-to-date book provides readers with an important overview of the most critical issues patent law is still facing today at the beginning of the twenty first century, on both sides of the Atlantic.
Buy Book in Print
Show Summary Details
You do not have access to this content

Chapter 6: Are Software Patents Something Special?

Reinier B. Bakels


Reinier B. Bakels INTRODUCTION Software patents are problematic in two different ways: it is controversial whether these patents are useful, and the bounds of software patentability are unclear. What is a software patent precisely? There is much confusion about the nature of software patents. As we will see shortly, it is not a clearly defined category. Therefore, it is irresponsible to make specific and generic statements about software patents. Still, doubts about software patent efficiency are not unfounded. As we will see, ‘software’ is primarily a risk factor for a socially undesirable use of patents. In European jurisdictions, software is excluded from patentability in certain cases, even if it is novel and non-obvious, and even under American patent law, software is not always patentable. In Europe, patents are only granted for technology, Americans exclude abstract ideas. But what is ‘technology’? And what ‘abstract’? Even after recent decisions of the EPO Enlarged Board of Appeal,1 and the US Federal Supreme Court2 the limits of software patentability are still not very clear. This contribution focuses on some selected topics that are essential for a better understanding of the widely voiced concerns about software patents, and opportunities for improvement. 1 Enlarged Board of Appeal of the EPO (hereinafter: EBoA) 12 May 2010, case G 3/08 (Programs for computers). 2 See U.S. Supreme Court 28 June 2010, case 08-964, 130 S.Ct. 3218, 2010 WL 2555192 (U.S.) (Bilski v. Kappos). 131 AREZZO PRINT.indd 131 25/10/2011 16:47 132 Biotechnology and software patent law WHAT...

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information

or login to access all content.